Acknowledgement
This study was supported by grant no.02-2022-0008 from the SNUBH Research Fund.
References
- Alvelo JL, Papademetris X, Mena-Hurtado C, Jeon S, Sumpio BE, Sinusas AJ, et al. Radiotracer imaging allows for noninvasive detection and quantification of abnormalities in angiosome foot perfusion in diabetic patients with critical limb ischemia and nonhealing wounds. Circ Cardiovasc Imaging 2018;11:e006932
- Fowkes FG, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 2013;382:1329-1340 https://doi.org/10.1016/S0140-6736(13)61249-0
- Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). J Vasc Surg 2000;31(1 Pt 2):S1-S296 https://doi.org/10.1016/S0741-5214(00)81002-2
- Ferrer MD, Esteban E, Liste F, Carrillo JM, Ramos JJ, Balastegui MT, et al. [The rabbit as an experimental model: technique for the induction of vascular lesions and incidents]. Radiologia 2010;52:45-50. Spanish https://doi.org/10.1016/j.rx.2009.09.011
- Waters RE, Terjung RL, Peters KG, Annex BH. Preclinical models of human peripheral arterial occlusive disease: implications for investigation of therapeutic agents. J Appl Physiol (1985) 2004;97:773-780 https://doi.org/10.1152/japplphysiol.00107.2004
- Schwartz RS, Chronos NA, Virmani R. Preclinical restenosis models and drug-eluting stents: still important, still much to learn. J Am Coll Cardiol 2004;44:1373-1385
- Schwartz RS, Edelman ER, Carter A, Chronos NA, Rogers C, Robinson KA, et al. Preclinical evaluation of drug-eluting stents for peripheral applications: recommendations from an expert consensus group. Circulation 2004;110:2498-2505 https://doi.org/10.1161/01.CIR.0000145164.85178.2E
- Nakazawa G, Nakano M, Otsuka F, Wilcox JN, Melder R, Pruitt S, et al. Evaluation of polymer-based comparator drug-eluting stents using a rabbit model of iliac artery atherosclerosis. Circ Cardiovasc Interv 2011;4:38-46 https://doi.org/10.1161/CIRCINTERVENTIONS.110.957654
- Metz J, Wolf O, Schmelz A, Pill J, Stegmeier KH, Hartig F. Atherosclerosis in the aorta of hypercholesterolemic rabbits and the influence of daltroban. Exp Pathol 1991;41:57-69 https://doi.org/10.1016/S0232-1513(11)80001-0
- Kolodgie FD, Katocs AS Jr, Largis EE, Wrenn SM, Cornhill JF, Herderick EE, et al. Hypercholesterolemia in the rabbit induced by feeding graded amounts of low-level cholesterol. Methodological considerations regarding individual variability in response to dietary cholesterol and development of lesion type. Arterioscler Thromb Vasc Biol 1996;16:1454-1464 https://doi.org/10.1161/01.ATV.16.12.1454
- Dornas WC, Oliveira TT, Augusto LE, Nagem TJ. Experimental atherosclerosis in rabbits. Arq Bras Cardiol 2010;95:272-278 https://doi.org/10.1590/S0066-782X2010001200020
- Yanni AE. Laboratory rabbit and high-cholesterol diet: what is taken for granted may not be so simple. Lab Anim 2014;48:349-350 https://doi.org/10.1177/0023677214544184
- Fan J, Kitajima S, Watanabe T, Xu J, Zhang J, Liu E, et al. Rabbit models for the study of human atherosclerosis: from pathophysiological mechanisms to translational medicine. Pharmacol Ther 2015;146:104-119 https://doi.org/10.1016/j.pharmthera.2014.09.009
- Phinikaridou A, Hallock KJ, Qiao Y, Hamilton JA. A robust rabbit model of human atherosclerosis and atherothrombosis. J Lipid Res 2009;50:787-797 https://doi.org/10.1194/jlr.M800460-JLR200
- Yanni AE. The laboratory rabbit: an animal model of atherosclerosis research. Lab Anim 2004;38:246-256 https://doi.org/10.1258/002367704323133628
- Zhou X, Mou Y, Shen X, Yang T, Liu J, Liu F, et al. The role of atorvastatin on the restenosis process post-PTA in a diabetic rabbit model. BMC Cardiovasc Disord 2016;16:153
- Jain M, Frobert A, Valentin J, Cook S, Giraud MN. The rabbit model of accelerated atherosclerosis: a methodological perspective of the iliac artery balloon injury. J Vis Exp 2017;128:55295
- Libby P. Inflammation in atherosclerosis. Nature 2002;420:868-874 https://doi.org/10.1038/nature01323
- Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135-1143 https://doi.org/10.1161/hc0902.104353
- Ip JH, Fuster V, Badimon L, Badimon J, Taubman MB, Chesebro JH. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol 1990;15:1667-1687 https://doi.org/10.1016/0735-1097(90)92845-S
- Verrier ED, Boyle EM Jr. Endothelial cell injury in cardiovascular surgery. Ann Thorac Surg 1996;62:915-922 https://doi.org/10.1016/S0003-4975(96)00528-0
- Gould RG. Lipid metabolism and atherosclerosis. Am J Med 1951;11:209-227 https://doi.org/10.1016/0002-9343(51)90107-6